Sofinnova Investments, Inc. - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is and the CUSIP is 75615P953. A total of 5 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Sofinnova Investments, Inc. ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$5,845,000
-51.0%
60,000
-59.6%
0.43%
-59.9%
Q3 2019$11,931,000148,6001.08%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 60,000$5,845,0000.43%
BOOTHBAY FUND MANAGEMENT, LLC 59$575,0000.04%
GROUP ONE TRADING, L.P. 3,600$351,0000.00%
SIMPLEX TRADING, LLC 60$584,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REATA PHARMACEUTICALS INC shareholders